Clinical Trial Update: Adipose Derived Cells for Chronic Obstructive Pulmonary Disease [NA]

View source ↗

Summary

A clinical trial evaluating adipose-derived cells for chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Bioheart adipose-derived cell therapy (adipose-derived cells)

Snippet

Sponsor: Bioheart, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: WITHDRAWN